From: NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer
Parameters | Total | Low expression | High expression | P-value |
---|---|---|---|---|
Age(y) | ||||
≤ 51 | 75 | 35 | 40 | |
> 51 | 74 | 27 | 47 | 0.207 |
Pathological Grading | ||||
I/II | 22 | 13 | 9 | |
III | 99 | 31 | 68 | 0.014 |
T stage | ||||
T1/T2 | 44 | 26 | 18 | |
T3 | 105 | 36 | 69 | 0.005 |
N stage | ||||
N0 | 111 | 57 | 54 | |
N1 | 38 | 5 | 33 | 0.000 |
M stage | ||||
M0 | 117 | 57 | 60 | |
M1 | 32 | 5 | 27 | 0.001 |
Clinical stages | ||||
I/II | 44 | 26 | 18 | |
III/IV | 105 | 36 | 69 | 0.005 |
Vital status | ||||
Alive | 71 | 44 | 27 | |
Dead | 78 | 18 | 60 | 0.000 |
Tumor recurrence | ||||
No | 29 | 17 | 12 | |
Yes | 120 | 45 | 75 | 0.038 |